Krystal Biotech, Inc. (KRYS)
300.88
+0.63
(+0.21%)
USD |
NASDAQ |
Nov 06, 16:00
299.88
-1.00
(-0.33%)
After-Hours: 20:00
Krystal Biotech Free Cash Flow : 310.08M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | 310.08M |
| June 30, 2026 | 257.78M |
| March 31, 2026 | 237.38M |
| December 31, 2025 | 188.91M |
| September 30, 2025 | 165.59M |
| June 30, 2025 | 185.44M |
| March 31, 2025 | 129.32M |
| December 31, 2024 | 119.18M |
| September 30, 2024 | 58.06M |
| June 30, 2024 | -22.76M |
| March 31, 2024 | -54.44M |
| December 31, 2023 | -100.60M |
| September 30, 2023 | -119.07M |
| June 30, 2023 | -129.81M |
| March 31, 2023 | -152.40M |
| December 31, 2022 | -153.55M |
| September 30, 2022 | -187.78M |
| June 30, 2022 | -182.29M |
| March 31, 2022 | -136.83M |
| December 31, 2021 | -116.27M |
| Date | Value |
|---|---|
| September 30, 2021 | -69.72M |
| June 30, 2021 | -52.42M |
| March 31, 2021 | -45.32M |
| December 31, 2020 | -40.93M |
| September 30, 2020 | -35.02M |
| June 30, 2020 | -29.49M |
| March 31, 2020 | -27.66M |
| December 31, 2019 | -25.11M |
| September 30, 2019 | -20.61M |
| June 30, 2019 | -17.96M |
| March 31, 2019 | -14.56M |
| December 31, 2018 | -11.74M |
| September 30, 2018 | -9.207M |
| June 30, 2018 | -7.545M |
| March 31, 2018 | -6.205M |
| December 31, 2017 | -4.10M |
| September 30, 2017 | -2.684M |
| June 30, 2017 | -1.886M |
| March 31, 2017 | -1.59M |
| December 31, 2016 | -1.326M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Alnylam Pharmaceuticals, Inc. | 752.13M |
| Ionis Pharmaceuticals, Inc. | -567.50M |
| Ultragenyx Pharmaceutical, Inc. | -446.77M |
| BridgeBio Pharma, Inc. | -369.80M |
| Cytokinetics, Inc. | -588.58M |